US 8357371
Methods for treating hypercholesterolemia using antibodies to PCSK9
granted A61KA61K2039/505A61K31/40
Quick answer
US patent 8357371 (Methods for treating hypercholesterolemia using antibodies to PCSK9) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K31/40, A61K39/3955, A61P